---
title: "君实生物-U (688180.SH) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/688180.SH/norm.md"
symbol: "688180.SH"
name: "君实生物-U"
parent: "https://longbridge.com/zh-CN/quote/688180.SH.md"
datetime: "2026-05-20T12:00:52.659Z"
locales:
  - [en](https://longbridge.com/en/quote/688180.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688180.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688180.SH/norm.md)
---

# 君实生物-U (688180.SH) — 财务报表

## 利润表 (CNY)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0200 | -0.2674 | -0.1806 | -0.1802 | -0.2400 |
| ROE | -1.38% | -18.26% | -11.63% | -11.86% | -16.37% |
| 营业收入 | 726.29M | 692.54M | 637.50M | 667.79M | 500.59M |
| 净利润 | -20.56M | -279.47M | -183.00M | -177.82M | -234.88M |
| 营业利润 | -92.13M | -333.31M | -110.78M | -206.11M | -263.40M |
| 毛利率 | 79.76% | 73.79% | 84.45% | 76.57% | 81.24% |
| 净利率 | -2.83% | -40.35% | -28.71% | -26.63% | -46.92% |
| 利润含金量 | -159.26% | - | - | - | - |

## 资产负债表 (CNY)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 14.15B | 12.38B | 11.69B | 11.68B | 10.90B |
| 权益乘数 | 2.32 | 2.04 | 1.86 | 1.83 | 1.92 |
| 每股净资产 | 5.75 | 5.88 | 6.06 | 6.21 | 5.71 |
| 资产周转率 | 0.2175 | 0.2157 | 0.2203 | 0.2057 | 0.1805 |
| 现金及短投 | 4.56B | 3.22B | 3.27B | 3.51B | 3.02B |
| 存货与应收 | 562.43M | 573.11M | 516.03M | 556.90M | 589.12M |
| 长期投资 | 4.95B | 4.87B | 4.39B | 4.26B | 4.20B |
| 净债务 | 1.41B | 928.98M | 315.21M | -13.59M | 371.17M |

## 现金流量表 (CNY)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | 57.85M | -176.16M | -14.02M | -305.06M | -24.33M |
| 投资现金流 | -541.37M | -671.92M | -355.94M | -211.23M | -341.63M |
| 融资现金流 | 1.79B | 686.73M | 158.21M | 997.59M | 386.78M |
| 自由现金流 | -466.21M | 89.77M | -389.88M | -346.89M | -272.94M |
| 现金流充裕率 | 6.71% | -21.16% | -1.56% | -78.85% | -2.06% |
| 举债与偿债 | 2.42B | 1.08B | 801.90M | 278.87M | 1.42B |
| 资本支出 | -251.91M | -258.74M | -195.80M | -152.56M | -161.20M |